Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

RYGCENTER SKJERN, TVÆRFAGLIG KIROPRAKTOR KLINIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6%   Bankruptcy risk   1.5% 0.7% 0.7% 0.6% 0.6% 0.7% 9.3% 9.3%   Credit score (0-100)   79 94 95 96 96 94 27 27   Credit rating   A AA AA AA AA AA BB BB   Credit limit (kDKK)   19.0 300.7 421.3 578.6 631.9 546.4 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,628 3,851 4,350 4,725 5,220 5,437 0.0 0.0   EBITDA   530 467 1,075 1,250 1,069 915 0.0 0.0   EBIT   318 277 844 1,095 974 789 0.0 0.0   Pre-tax profit (PTP)   49.9 245.1 1,111.7 1,290.8 1,406.5 1,937.4 0.0 0.0   Net earnings   -16.3 196.5 925.3 1,027.6 1,131.1 1,510.8 0.0 0.0   Pre-tax profit without non-rec. items   49.9 245 1,112 1,291 1,406 1,937 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   387 375 370 302 246 421 0.0 0.0   Shareholders equity total   2,222 2,018 2,943 3,971 4,602 4,113 3,913 3,913   Interest-bearing liabilities   1,654 975 0.0 0.0 0.0 31.1 0.0 0.0   Balance sheet total (assets)   4,233 3,352 3,478 4,591 5,230 4,756 3,913 3,913   Net Debt   -781 -1,586 -2,662 -3,336 -3,472 -4,060 -3,913 -3,913     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,628 3,851 4,350 4,725 5,220 5,437 0.0 0.0   Gross profit growth   4.0% 6.1% 13.0% 8.6% 10.5% 4.2% -100.0% 0.0%   Employees   7 7 6 8 9 8 0 0   Employee growth %   16.7% 0.0% -14.3% 33.3% 12.5% -11.1% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   4,233 3,352 3,478 4,591 5,230 4,756 3,913 3,913   Balance sheet change%   20.5% -20.8% 3.8% 32.0% 13.9% -9.0% -17.7% 0.0%   Added value   529.6 467.0 1,074.9 1,250.1 1,129.8 915.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -140 -302 -335 -273 -151 49 -421 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   8.8% 7.2% 19.4% 23.2% 18.7% 14.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   11.2% 7.9% 33.2% 32.2% 28.7% 38.8% 0.0% 0.0%   ROI %   12.1% 8.6% 37.7% 37.3% 32.6% 44.0% 0.0% 0.0%   ROE %   -0.7% 9.3% 37.3% 29.7% 26.4% 34.7% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   52.5% 60.2% 84.6% 86.5% 88.0% 86.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -147.5% -339.6% -247.6% -266.9% -324.7% -443.7% 0.0% 0.0%   Gearing %   74.4% 48.3% 0.0% 0.0% 0.0% 0.8% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   30.6% 4.3% 4.7% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   1.4 2.2 6.0 7.2 8.3 7.1 0.0 0.0   Current Ratio   1.4 2.2 6.1 7.2 8.4 7.1 0.0 0.0   Cash and cash equivalent   2,435.0 2,560.7 2,661.9 3,336.0 3,472.0 4,090.8 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   237.8 -146.4 600.9 1,646.5 1,983.1 237.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   76 67 179 156 126 114 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   76 67 179 156 119 114 0 0   EBIT / employee   45 40 141 137 108 99 0 0   Net earnings / employee   -2 28 154 128 126 189 0 0